Your browser doesn't support javascript.
loading
Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance.
Klümper, Niklas; Ralser, Damian J; Ellinger, Jörg; Roghmann, Florian; Albrecht, Julia; Below, Eduard; Alajati, Abdullah; Sikic, Danijel; Breyer, Johannes; Bolenz, Christian; Zengerling, Friedemann; Erben, Philipp; Schwamborn, Kristina; Wirtz, Ralph M; Horn, Thomas; Nagy, Dora; Toma, Marieta; Kristiansen, Glen; Büttner, Thomas; Hahn, Oliver; Grünwald, Viktor; Darr, Christopher; Erne, Eva; Rausch, Steffen; Bedke, Jens; Schlack, Katrin; Abbas, Mahmoud; Zschäbitz, Stefanie; Schwab, Constantin; Mustea, Alexander; Adam, Patrick; Manseck, Andreas; Wullich, Bernd; Ritter, Manuel; Hartmann, Arndt; Gschwend, Jürgen; Weichert, Wilko; Erlmeier, Franziska; Hölzel, Michael; Eckstein, Markus.
Affiliation
  • Klümper N; Department of Urology and Pediatric Urology, University Medical Center Bonn (UKB), Bonn, Germany.
  • Ralser DJ; Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany.
  • Ellinger J; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.
  • Roghmann F; BRIDGE-Consortium Germany e.V., Mannheim, Germany.
  • Albrecht J; Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany.
  • Below E; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.
  • Alajati A; Department of Gynaecology and Gynaecological Oncology, University Medical Center Bonn (UKB), Bonn, Germany.
  • Sikic D; Department of Urology and Pediatric Urology, University Medical Center Bonn (UKB), Bonn, Germany.
  • Breyer J; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.
  • Bolenz C; BRIDGE-Consortium Germany e.V., Mannheim, Germany.
  • Zengerling F; Department of Urology, Marien Hospital, Ruhr-University Bochum, Herne, Germany.
  • Erben P; Department of Urology and Pediatric Urology, University Medical Center Bonn (UKB), Bonn, Germany.
  • Schwamborn K; Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany.
  • Wirtz RM; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.
  • Horn T; Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany.
  • Nagy D; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.
  • Toma M; Department of Urology and Pediatric Urology, University Medical Center Bonn (UKB), Bonn, Germany.
  • Kristiansen G; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.
  • Büttner T; BRIDGE-Consortium Germany e.V., Mannheim, Germany.
  • Hahn O; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Grünwald V; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Darr C; Bavarian Center for Cancer Research (Bayerisches Zentrum für Krebsforschung, BZKF), Erlangen, Germany.
  • Erne E; BRIDGE-Consortium Germany e.V., Mannheim, Germany.
  • Rausch S; Bavarian Center for Cancer Research (Bayerisches Zentrum für Krebsforschung, BZKF), Erlangen, Germany.
  • Bedke J; Department of Urology, University of Regensburg, Caritas St. Josef Hospital, Regensburg, Germany.
  • Schlack K; BRIDGE-Consortium Germany e.V., Mannheim, Germany.
  • Abbas M; Department of Urology and Pediatric Urology, University Hospital Ulm, University of Ulm, Ulm, Germany.
  • Zschäbitz S; BRIDGE-Consortium Germany e.V., Mannheim, Germany.
  • Schwab C; Department of Urology and Pediatric Urology, University Hospital Ulm, University of Ulm, Ulm, Germany.
  • Mustea A; BRIDGE-Consortium Germany e.V., Mannheim, Germany.
  • Adam P; Department of Urology and Urosurgery, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany.
  • Manseck A; Bavarian Center for Cancer Research (Bayerisches Zentrum für Krebsforschung, BZKF), Erlangen, Germany.
  • Wullich B; Institute of Pathology, Technical University Munich, Munich, Germany.
  • Ritter M; BRIDGE-Consortium Germany e.V., Mannheim, Germany.
  • Hartmann A; STRATIFYER Molecular Pathology, Cologne, Germany.
  • Gschwend J; Bavarian Center for Cancer Research (Bayerisches Zentrum für Krebsforschung, BZKF), Erlangen, Germany.
  • Weichert W; Department of Urology, Technical University Munich, Munich, Germany.
  • Erlmeier F; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.
  • Hölzel M; Institute of Pathology, University Medical Center Bonn (UKB), Bonn, Germany.
  • Eckstein M; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.
Clin Cancer Res ; 29(8): 1496-1505, 2023 04 14.
Article in En | MEDLINE | ID: mdl-36534531
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Type of study: Guideline / Risk_factors_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Type of study: Guideline / Risk_factors_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Country of publication: